Fludarabine and hemolytic anemia in chronic lymphocytic leukemia

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

Leukemia·2026

Functional modulation of caecal fermentation and microbiota in rat by feeding bean husk as a dietary fibre supplement.

Beneficial microbes·2018

CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3.

Leukemia & lymphoma·2016

Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.

Bone marrow transplantation·2016

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

Leukemia·2016

Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease.

Leukemia·2016

Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

The Patient Who Could Not Die.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Prognostic Role of Blood Inflammatory Composite Biomarkers in Dvt After Lower Extremity Fractures.

The Iowa orthopaedic journal·2026

Pattern of blood utilization and blood wastage at blood bank of a tertiary care hospital in Lahore.

Pakistan journal of medical sciences·2026

RUNX1-IT1 and AK026392.1 long non-coding RNAs as early predictors of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in acute leukemia.

Caspian journal of internal medicine·2026

Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial.

Research and practice in thrombosis and haemostasis·2026

Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies.

Research and practice in thrombosis and haemostasis·2026

Endoscopic combined intrarenal surgery for staghorn calculus in a horseshoe kidney with double collecting system: A case report.

Urology case reports·2026

Related Experiment Videos

Fludarabine and hemolytic anemia in chronic lymphocytic leukemia

Related Concept Videos

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

Functional modulation of caecal fermentation and microbiota in rat by feeding bean husk as a dietary fibre supplement.

CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3.

Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease.

Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.

Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.

Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial.

The Patient Who Could Not Die.

Prognostic Role of Blood Inflammatory Composite Biomarkers in Dvt After Lower Extremity Fractures.

Pattern of blood utilization and blood wastage at blood bank of a tertiary care hospital in Lahore.

RUNX1-IT1 and AK026392.1 long non-coding RNAs as early predictors of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in acute leukemia.

Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial.

Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies.

Endoscopic combined intrarenal surgery for staghorn calculus in a horseshoe kidney with double collecting system: A case report.

Related Experiment Videos

Fludarabine and hemolytic anemia in chronic lymphocytic leukemia

Related Concept Videos

Related Articles